JDR Woodhead Publishing
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kawahara, T.
Right arrow Articles by Ebisu, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kawahara, T.
Right arrow Articles by Ebisu, S.

Effects of Cyclosporin-A-induced Immunosuppression on Periapical Lesions in Rats

T. Kawahara1, S. Murakami2, Y. Noiri1,*, A. Ehara1, N. Takemura1, S. Furukawa2, and S. Ebisu1

1 Departments of Restorative Dentistry and Endodontology, and
2 Oral and Maxillofacial Radiology, Osaka University Graduate School of Dentistry, 1-8, Yamadaoka, Suita, Osaka 565-0871, Japan;



View larger version (27K):

[in a new window]
 
Figure 1. Lesion volume measurements. (a) CT images analyzed by the image analysis system. (b) Data are expressed as the percentages of lesion volume at week 0 (weeks 0–4, n = 10; weeks 4–8, n = 4) and shown as means ± SD. Statistical analyses were performed by means of the Dunnett test. Significance (*) was determined at a level of p < 0.05.

 


View larger version (103K):

[in a new window]
 
Figure 2. Pathological evaluation. (a,b) Control group at week 4. (c,d) 20 mg/kg/day group at week 4. (e,f) Control group at week 8. (g,h) 20 mg/kg/day group at week 8. Panels b, d, f, and h are high-magnification views of the periapical lesions shown in panels a, c, e, and g, respectively. AA, Apical Abscess; CE, Cementum; B, Bone. Scale bars: a, c, e, g = 250 µm; b, d, f, h = 50 µm.

 


View larger version (90K):

[in a new window]
 
Figure 3. Immunohistochemical staining at week 4. (a) Anti-CD3 staining of the control group. (b) Anti-CD3 staining of the 20 mg/kg/day group. (c) Anti-CD25 staining of the control group. (d) Anti-CD25 staining of the 20 mg/kg/day group. Scale bars = 100 µm. (e) CD3+ cell-counts in the lesions of each group (n = 6). (f) CD25+ cell-counts in the lesions of each group (n = 6). (g) ED1+ cell-counts in the lesions of each group (n = 6). (h) TRAP staining of the control group. (i) TRAP staining of the 20 mg/kg/day group. Values are the means ± SD. *A value of p < 0.01 was determined as statistically different in comparison with the controls.

 


View larger version (100K):

[in a new window]
 
Figure 4. Immunohistochemical staining at week 8. (a) Anti-CD3 staining of the control group. (b) Anti-CD3 staining of the 20 mg/kg/day group. (c) Anti-CD25 staining of the control group. (d) Anti-CD25 staining of the 20 mg/kg/day group. Scale bars = 100 µm. (e) CD3+ cell-counts in the lesions of each group (n = 4). (f) CD25+ cell-counts in the lesions of each group (n = 4). (g) ED1+ cell-counts in the lesions of each group (n = 4). (h) TRAP staining of the control group. (i) TRAP staining of the 20 mg/kg/day group. Values are the means ± SD. *p < 0.05. **A value of p < 0.01 was determined as statistically different in comparison with controls.

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
IADR Journals Advances in Dental Research ®
Journal of Dental Research ® Critical Reviews (1990-2004)
Copyright © 2004 Institutional Access Guidelines